NCT00036959View on ClinicalTrials.gov

ABT-751 in Treating Young Patients With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell TumorKidney CancerLiver CancerNeuroblastomaOvarian CancerSarcomaUnspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG

ABT-751

Trial Locations (3)

60614

Children's Memorial Hospital - Chicago, Chicago

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

19104-4318

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00036959 - ABT-751 in Treating Young Patients With Refractory Solid Tumors | Biotech Hunter | Biotech Hunter